181 related articles for article (PubMed ID: 28072973)
81. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
[TBL] [Abstract][Full Text] [Related]
82. ER-/PR+ subset of invasive breast carcinoma (IBC): a distinct phenotype with good prognosis.
Stolnicu S; Bauer O; Naznean A; Podoleanu C; Georgescu R
Pol J Pathol; 2018; 69(3):311-313. PubMed ID: 30509058
[TBL] [Abstract][Full Text] [Related]
83. [Extensive peritumoral retraction clefts and prognosis in invasive breast carcinomas of no specific type].
Deng HY; Wang XR; Yue M; Zhang LL; Li F; Wang XL; Liu YP
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):196-200. PubMed ID: 29534360
[No Abstract] [Full Text] [Related]
84. Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Diessner J; Van Ewijk R; Weiss CR; Janni W; Wischnewsky MB; Kreienberg R; Hancke K; Blettner M; Wöckel A; Schwentner L
Arch Gynecol Obstet; 2015 Sep; 292(3):655-64. PubMed ID: 25814296
[TBL] [Abstract][Full Text] [Related]
85. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
86. Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis.
Yin YX; Shen F; Pei H; Ding Y; Zhao H; Zhao M; Chen Q
Tumour Biol; 2012 Oct; 33(5):1581-7. PubMed ID: 22644676
[TBL] [Abstract][Full Text] [Related]
87. HtrA3 is negatively correlated with lymph node metastasis in invasive ductal breast cancer.
Yin Y; Wu M; Nie G; Wang K; Wei J; Zhao M; Chen Q
Tumour Biol; 2013 Dec; 34(6):3611-7. PubMed ID: 23812730
[TBL] [Abstract][Full Text] [Related]
88. IMP3 expression in triple-negative breast carcinoma.
Sidoni A; Cartaginese F
Hum Pathol; 2010 Sep; 41(9):1355-6; author reply 1356-7. PubMed ID: 20708461
[No Abstract] [Full Text] [Related]
89. Expression of c-met is a strong independent prognostic factor in breast carcinoma.
Ghoussoub RA; Dillon DA; D'Aquila T; Rimm EB; Fearon ER; Rimm DL
Cancer; 1998 Apr; 82(8):1513-20. PubMed ID: 9554529
[TBL] [Abstract][Full Text] [Related]
90. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.
Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J
Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377
[TBL] [Abstract][Full Text] [Related]
91. ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma.
Xiang L; Su P; Xia S; Liu Z; Wang Y; Gao P; Zhou G
Diagn Pathol; 2011 Sep; 6():90. PubMed ID: 21943250
[TBL] [Abstract][Full Text] [Related]
92. [Correlations of Androgen Receptor Expression with Molecular Subtypes and Clinopathological Features of Invasive Breast Carcinoma of No Special Type in Tibet].
Luo HH; Jiang Y; BIANbazhaxi ; Wang Q; NImazhuoma ; Wang H; Wei Q; Liao RQ; CIrenquzhen
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Dec; 44(6):1033-1039. PubMed ID: 36621794
[TBL] [Abstract][Full Text] [Related]
93. Prognostic significance of fatty acid binding protein-4 in the invasive ductal carcinoma of the breast.
Cui Y; Song M; Kim SY
Pathol Int; 2019 Feb; 69(2):68-75. PubMed ID: 30694572
[TBL] [Abstract][Full Text] [Related]
94. Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis.
Yao Y; Wang X; Jiang L; Shao X; Zhu X; He S
Medicine (Baltimore); 2018 Dec; 97(52):e13899. PubMed ID: 30593202
[TBL] [Abstract][Full Text] [Related]
95. Progesterone receptor downregulates breast cancer resistance protein expression via binding to the progesterone response element in breast cancer.
Wu X; Zhang X; Zhang H; Su P; Li W; Li L; Wang Y; Liu W; Gao P; Zhou G
Cancer Sci; 2012 May; 103(5):959-67. PubMed ID: 22348324
[TBL] [Abstract][Full Text] [Related]
96. Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.
Arias-Pulido H; Chaher N; Gong Y; Qualls C; Vargas J; Royce M
BMC Cancer; 2012 Jul; 12():298. PubMed ID: 22813402
[TBL] [Abstract][Full Text] [Related]
97. Foxo3a expression is a prognostic marker in breast cancer.
Jiang Y; Zou L; Lu WQ; Zhang Y; Shen AG
PLoS One; 2013; 8(8):e70746. PubMed ID: 23967095
[TBL] [Abstract][Full Text] [Related]
98. SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast Cancer.
van Reesema LLS; Zheleva V; Winston JS; Jansen RJ; O'Connor CF; Isbell AJ; Bian M; Qin R; Bassett PT; Hinson VJ; Dorsch KA; Kirby BW; Van Sciver RE; Tang-Tan AM; Harden EA; Chang DZ; Allen CA; Perry RR; Hoefer RA; Tang AH
EBioMedicine; 2016 Sep; 11():183-198. PubMed ID: 27569656
[TBL] [Abstract][Full Text] [Related]
99. [Correlation between the mRNA levels of BCRP and LUNX genes and pathological types and stages of patients with non-small cell lung cancer].
Chen D; Han W; Wang P; Ma H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Feb; 40(2):202-207. PubMed ID: 36709941
[TBL] [Abstract][Full Text] [Related]
100. Detection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.
Williams V; Grosset AA; Zamorano Cuervo N; St-Pierre Y; Sylvestre MP; Gaboury L; Grandvaux N
BMC Cancer; 2017 May; 17(1):356. PubMed ID: 28532474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
